AU4822299A – Imidazolyl derivatives
– Google Patents
AU4822299A – Imidazolyl derivatives
– Google Patents
Imidazolyl derivatives
Info
Publication number
AU4822299A
AU4822299A
AU48222/99A
AU4822299A
AU4822299A
AU 4822299 A
AU4822299 A
AU 4822299A
AU 48222/99 A
AU48222/99 A
AU 48222/99A
AU 4822299 A
AU4822299 A
AU 4822299A
AU 4822299 A
AU4822299 A
AU 4822299A
Authority
AU
Australia
Prior art keywords
imidazolyl derivatives
imidazolyl
derivatives
Prior art date
1998-06-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48222/99A
Inventor
Zheng Xin Dong
Yeelana Shen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1998-06-16
Filing date
1999-06-11
Publication date
2000-01-05
1999-06-11
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
filed
Critical
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
2000-01-05
Publication of AU4822299A
publication
Critical
patent/AU4822299A/en
Status
Abandoned
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P13/00—Drugs for disorders of the urinary system
A61P13/12—Drugs for disorders of the urinary system of the kidneys
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P27/00—Drugs for disorders of the senses
A61P27/02—Ophthalmic agents
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P31/10—Antimycotics
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P31/12—Antivirals
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P35/00—Antineoplastic agents
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P35/00—Antineoplastic agents
A61P35/02—Antineoplastic agents specific for leukemia
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P9/00—Drugs for disorders of the cardiovascular system
A61P9/08—Vasodilators for multiple indications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P9/00—Drugs for disorders of the cardiovascular system
A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
AU48222/99A
1998-06-16
1999-06-11
Imidazolyl derivatives
Abandoned
AU4822299A
(en)
Applications Claiming Priority (5)
Application Number
Priority Date
Filing Date
Title
US9814198A
1998-06-16
1998-06-16
US8948398P
1998-06-16
1998-06-16
US60089483
1998-06-16
US09098141
1998-06-16
PCT/US1999/013303
WO1999065898A1
(en)
1998-06-16
1999-06-11
Imidazolyl derivatives
Publications (1)
Publication Number
Publication Date
AU4822299A
true
AU4822299A
(en)
2000-01-05
Family
ID=26780620
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU48222/99A
Abandoned
AU4822299A
(en)
1998-06-16
1999-06-11
Imidazolyl derivatives
Country Status (12)
Country
Link
EP
(1)
EP1097150B1
(en)
JP
(1)
JP2002518387A
(en)
AR
(1)
AR019866A1
(en)
AT
(1)
ATE262520T1
(en)
AU
(1)
AU4822299A
(en)
CA
(1)
CA2335435A1
(en)
DE
(1)
DE69915835T2
(en)
DK
(1)
DK1097150T3
(en)
ES
(1)
ES2216535T3
(en)
NO
(1)
NO320835B1
(en)
TW
(1)
TW577885B
(en)
WO
(1)
WO1999065898A1
(en)
Families Citing this family (1)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
FR2825706B1
(en)
*
2001-06-06
2003-12-12
Pf Medicament
NOVEL BENZOTHIENYL OR INDOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS PRENYL TRANSFERASE PROTEIN INHIBITORS
Family Cites Families (8)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
CA2002859C
(en)
*
1988-11-29
1998-12-29
Jean P. F. Van Wauwe
Method of treating epithelial disorders
GB9212833D0
(en)
*
1992-06-17
1992-07-29
Glaxo Group Ltd
Chemical compounds
TW316902B
(en)
*
1994-12-28
1997-10-01
Janssen Pharmaceutica Nv
US5756528A
(en)
*
1995-06-06
1998-05-26
Merck & Co., Inc.
Inhibitors of farnesyl-protein transferase
TW349948B
(en)
*
1995-10-31
1999-01-11
Janssen Pharmaceutica Nv
Farnesyl transferase inhibiting 2-quinolone derivatives
US6037350A
(en)
*
1995-12-08
2000-03-14
Janssen Pharmaceutica, N.V.
Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quionlinone derivatives
EP0891361A1
(en)
*
1996-04-03
1999-01-20
Merck & Co., Inc.
Inhibitors of farnesyl-protein transferase
TW591030B
(en)
*
1997-03-10
2004-06-11
Janssen Pharmaceutica Nv
Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles
1999
1999-06-11
DK
DK99931792T
patent/DK1097150T3/en
active
1999-06-11
CA
CA002335435A
patent/CA2335435A1/en
not_active
Abandoned
1999-06-11
WO
PCT/US1999/013303
patent/WO1999065898A1/en
active
IP Right Grant
1999-06-11
DE
DE69915835T
patent/DE69915835T2/en
not_active
Expired – Fee Related
1999-06-11
AU
AU48222/99A
patent/AU4822299A/en
not_active
Abandoned
1999-06-11
EP
EP99931792A
patent/EP1097150B1/en
not_active
Expired – Lifetime
1999-06-11
AT
AT99931792T
patent/ATE262520T1/en
not_active
IP Right Cessation
1999-06-11
ES
ES99931792T
patent/ES2216535T3/en
not_active
Expired – Lifetime
1999-06-11
JP
JP2000554723A
patent/JP2002518387A/en
active
Pending
1999-06-15
AR
ARP990102856A
patent/AR019866A1/en
unknown
1999-08-19
TW
TW088110018A
patent/TW577885B/en
not_active
IP Right Cessation
2000
2000-12-15
NO
NO20006401A
patent/NO320835B1/en
unknown
Also Published As
Publication number
Publication date
EP1097150A1
(en)
2001-05-09
DE69915835D1
(en)
2004-04-29
JP2002518387A
(en)
2002-06-25
NO320835B1
(en)
2006-01-30
ES2216535T3
(en)
2004-10-16
NO20006401L
(en)
2000-12-15
DK1097150T3
(en)
2004-07-26
NO20006401D0
(en)
2000-12-15
ATE262520T1
(en)
2004-04-15
WO1999065898A1
(en)
1999-12-23
DE69915835T2
(en)
2005-03-24
TW577885B
(en)
2004-03-01
CA2335435A1
(en)
1999-12-23
AR019866A1
(en)
2002-03-20
EP1097150B1
(en)
2004-03-24
Similar Documents
Publication
Publication Date
Title
AU5283999A
(en)
2000-02-21
Substituted pyrazole derivatives
PL347139A1
(en)
2002-03-25
Imidazolyl derivatives
AU9459398A
(en)
1999-05-03
Pyrazole derivatives
AU1151099A
(en)
1999-05-17
Azaoxindole derivatives
AU1825899A
(en)
1999-07-05
Dota-biotin derivatives
AU7935398A
(en)
1999-01-25
Diaminorhodamine derivatives
AU6117998A
(en)
1998-10-20
3-oxadiazolylquinoxaline derivatives
AU7553198A
(en)
1998-12-30
Pyrazole derivatives
AU5410498A
(en)
1998-07-03
Pyrazole derivatives
AU7813598A
(en)
1998-12-21
Betulinol derivatives
AU1174199A
(en)
1999-06-15
Biphenylamidine derivatives
AU6729498A
(en)
1998-10-20
Thiazolimine derivatives
AU1690199A
(en)
1999-07-19
Novel imidazole derivatives
AU5688499A
(en)
2000-03-21
Non-knotting line
AU5577198A
(en)
1998-08-18
Pyrazole derivatives
AU6228299A
(en)
2000-05-22
2-substituted-d-homooxasteroid derivatives
AU1562199A
(en)
1999-06-16
Amino-benzothiazole derivatives
AU6115798A
(en)
1998-09-18
Saponarin derivatives
AU2640999A
(en)
1999-09-15
1-azaindolizine derivatives
AU4141099A
(en)
1999-12-06
Pyrazolyldioxothiochromanoyl derivatives
AU5239899A
(en)
2000-02-21
Amidophosphate derivatives
AU2894099A
(en)
1999-09-27
Phenanthrofuran derivatives
AU1691399A
(en)
1999-07-19
5-arylpyrrole derivatives
AU1055399A
(en)
1999-11-08
Rollerboard
AU4822299A
(en)
2000-01-05
Imidazolyl derivatives
Legal Events
Date
Code
Title
Description
2001-03-08
MK6
Application lapsed section 142(2)(f)/reg. 8.3(3) – pct applic. not entering national phase
